FDA approves extended-release, single-entity hydrocodone product

Zohydro ER, a Schedule II controlled substance under the Controlled Substances Act, is the first FDA-approved single-entity (not combined with an analgesic such as acetaminophen) and extended-release hydrocodone product...
Pain / Anesthetics News From Medical News Today

Share:

Related Content